Why biotechnology stocks have more room to run

Graig Suvannavejh, managing director & senior analyst for biopharmaceuticals & biotechnology at Mizuho, sits down with InvestmentNews anchor Gregg Greenberg to highlight the best places to invest in biotech as the sector continues to gain momentum.
  • May 12, 2026

Graig Suvannavejh, managing director & senior analyst for biopharmaceuticals & biotechnology at Mizuho, sits down with InvestmentNews anchor Gregg Greenberg to highlight the best places to invest in biotech as the sector continues to gain momentum.

More: IN THE NASDAQ
Breaking down the decision to add private market assets to a portfolio

Breaking down the decision to add private market assets to a portfolio

Is the market at an inflection point for private market assets?

Is the market at an inflection point for private market assets?

Autocallable ETFs are on the rise. Here’s why.

Autocallable ETFs are on the rise. Here’s why.